Objetives: To describe the events supposedly attributable to immunization with the Pfizer-BioNTech® COVID-19 vaccine in children aged 5 to 17 years in the state of Puebla, Mexico.
Methods: Observational, cross-sectional and descriptive study carried out based on the analysis of reports of events supposedly attributable to immunization in children aged 5 to 17 years, who received the vaccine with the BNT162b2 mRNA platform for COVID-19, since January. to December 2022.
Objective: To determine prevalence, causes and risk factors of ADE in hospitalized patients.
Methods: Analytical, observational, case-control study of patients with ADE. For statistical analysis, the following were calculated: percentages, frequencies, averages; odds ratio, χ test and multiple binary logistic regression.
Objective: To determine prevalence, causes and risk factors of ADE in hospitalized patients of a General Hospital.
Methods: Observational and analytical case-control study, carried out in patients hospitalized for adverse drug events, treated at the Hospital General Dr. Eduardo Vázquez N, in Puebla, Mexico, between, June 2019 to June 2021.
Background: Mexico has a very high mortality rate from COVID19, risk factors, clinical manifestations of our population are unknown.
Objective: To know risk factors for mortality from COVID19 in hospitalized patients of the Secretary of Health (SSA) Puebla, and clinical characteristics.
Material And Methods: Case-control, observational, retrospective, cross-sectional study in COVID-19 patients.
Objective: To determine anxiety and depression frequency in residents from hospital centers during COVID-19 pandemic.
Methods: A descriptive, observational, cross-sectional study was carried out from June to December 2020. Residents from hospitals of Secretary of Health, Puebla, were identified.